SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

GSK investing $60m in greener manufacturing at Singapore amoxicillin plant

GSK is investing £38m ($60m) in enzymatic manufacturing at an antibiotic facility in Singapore which the firm says is greener and more efficient than traditional approaches.

GMP assessments should consider environmental impact say campaigners

A group calling for GMP assessments to consider the environmental impact of API production says pollution generated by suppliers in China is furthering the spread of resistant superbugs.

Biogen looks to build $1.1bn manufacturing plant in Switzerland

Biotech company Biogen plans to invest one billion Swiss francs ($1.1bn) in Solothurn, Switzerland to build a new production plant that will create about 400 new jobs beginning in 2019.

US FDA extends track-and-trace deadline for pharmacies

The US FDA says has granted a four month amnesty to pharmacies which do not comply with new track-and-trace regulations that come into force today.

New logo will help patients tell legit EU web pharmacies from illegal sites says EC

Europeans who want to fund organised crime can now do so more easily by buying meds from web pharmacies that lack a new logo launched by the EC to stop the sale of fakes online.

Sequenom case leaves pharma confused over patent law

US IP rules and a string of recent court cases are reducing the types of inventions pharma companies can patent, and “calling into question entire portfolios,” says a specialist lawyer. 

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...